3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
6
Breast Neoplasms
5
Prostatic Neoplasms
4
Hematologic Neoplasms
4
Colorectal Neoplasms
4
Melanoma
3
Lung Neoplasms
3
Pancreatic Neoplasms
2
Malignant Solid Neoplasm
2
Leukemia, Myeloid, Acute
2
Hematopoietic and Lymphatic System Neoplasm
2
Head and Neck Neoplasms
2
COVID-19
2
Urologic Neoplasms
1
Urologic Diseases
1
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spondylitis, Ankylosing
1
Speech
1
Seroma
1
Rectal Neoplasms
1
Psoriasis
1
Progressive Metastatic Castrate Resistant Prostate Cancer
1
Postoperative Complications
1
Peritoneal Neoplasms
1
Parotid Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Interventions
pembrolizumab
18
Specimen Handling
16
Magnetic Resonance Spectroscopy
11
Biopsy
11
Paclitaxel
8
Carboplatin
8
trastuzumab deruxtecan
6
Pemetrexed
6
Nivolumab
6
Irinotecan
6
Fulvestrant
6
Bevacizumab
6
Radiosurgery
5
Leucovorin
5
Gemcitabine
5
Fluorouracil
5
Cetuximab
5
palbociclib
4
Oxaliplatin
4
Letrozole
4
Cisplatin
4
olaparib
3
durvalumab
3
Taxes
3
Ipilimumab
3
Docetaxel
3
Capecitabine
3
130-nm albumin-bound paclitaxel
3
sacituzumab govitecan
2
ribociclib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Standard of Care
×
30 days
×
Clear all
No trials found.